Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China flag China · Delayed Price · Currency is CNY
4.630
+0.070 (1.54%)
Feb 4, 2026, 3:00 PM CST

SHA:603669 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
172.79254.09343.42575.76986.941,567
Trading Asset Securities
18.5331.22390.59389.51579.13180
Cash & Short-Term Investments
191.32285.31734.01965.281,5661,747
Cash Growth
-42.46%-61.13%-23.96%-38.36%-10.36%101.55%
Accounts Receivable
295.84243.265.692.21124.89172.17
Other Receivables
3.284.692.183.537.719.73
Receivables
299.12247.8967.7895.74132.61181.9
Inventory
57.1227.8856.7749.1451.6769.06
Other Current Assets
27.7125.5322.9721.8937.9540.87
Total Current Assets
575.27586.61881.531,1321,7882,039
Property, Plant & Equipment
448.99469.67505.35496.32484.53465.47
Long-Term Investments
61.6875.67100.8777.866.6763.05
Goodwill
----2.032.03
Other Intangible Assets
95.72100.9108.44115.79124.1102.7
Long-Term Deferred Tax Assets
--2.20.216.834.12
Long-Term Deferred Charges
12.2614.2317.1520.123.9226.5
Other Long-Term Assets
7.318.259.0213.221813.52
Total Assets
1,2011,2551,6251,8552,5142,716
Accounts Payable
103.8389.1385.549.2648.5339.02
Accrued Expenses
2.2522.0611.9514.625.2565.4
Short-Term Debt
5-117.41205.24460.29389.75
Current Portion of Long-Term Debt
2.360.420.38-85.06-
Current Portion of Leases
-1.772.641.143.19-
Current Income Taxes Payable
13.630.030.310.021.2811.58
Current Unearned Revenue
8.576.8810.488.846.6111.18
Other Current Liabilities
49.3499.0314.4423.3318.64214.65
Total Current Liabilities
184.99219.31243.11302.42648.85731.57
Long-Term Debt
273.21257.99439.34412.52385.91497.54
Long-Term Leases
4.074.075.841.0714.77-
Long-Term Unearned Revenue
2.222.412.84.095.817.22
Long-Term Deferred Tax Liabilities
1.431.782.420.740.19-
Total Liabilities
465.93485.57693.52720.841,0561,236
Common Stock
721.24721.24721.24721.24721.23713.44
Additional Paid-In Capital
262.69262.65255.64255.63255.54193.81
Retained Earnings
-196.83-162.32-31.56119.94387.95464.73
Treasury Stock
-110.02-110.02-108.37-56.26--
Comprehensive Income & Other
58.2158.2194.0994.0994.11107.89
Shareholders' Equity
735.3769.76931.041,1351,4591,480
Total Liabilities & Equity
1,2011,2551,6251,8552,5142,716
Total Debt
284.64264.26565.61619.97949.22887.29
Net Cash (Debt)
-93.3221.05168.4345.3616.84859.69
Net Cash Growth
--87.50%-51.23%-44.02%-28.25%39.40%
Net Cash Per Share
-0.130.030.230.480.861.13
Filing Date Shares Outstanding
703.54703.54703.83721.24721.23713.44
Total Common Shares Outstanding
703.54703.54703.83721.24721.23713.44
Working Capital
390.28367.3638.42829.621,1391,307
Book Value Per Share
1.051.091.321.572.022.07
Tangible Book Value
639.58668.86822.611,0191,3331,375
Tangible Book Value Per Share
0.910.951.171.411.851.93
Buildings
-374.09378.47369.78316.92320.8
Machinery
-162.03187.09191.33197.49189.79
Construction In Progress
-228.22220.06190.18187.96159.3
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.